2 completed, 1 suspended. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Suspended 1 |
| Phase 1 | 2 | Completed 1, Suspended 1 |
Follow Ascend Biopharmaceuticals Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor ASN-002 - Basal Cell Carcinoma, Basal Cell Nevus Syndrome | Phase 2 | Completed | Ascend Biopharmaceuticals Ltd | 21 | 2020-07-16 | 2024-04-10 |
| Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS) ASN-002 - Basal Cell Carcinoma in Basal Cell Nevus Syndrome | Phase 1 / Phase 2 | Suspended | Ascend Biopharmaceuticals Ltd | 24 | 2017-12-01 | 2023-02-06 |
| A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma ASN-002, 5-FU - Basal Cell Nevus Syndrome, Skin Neoplasm | Phase 1 / Phase 2 | Completed | Ascend Biopharmaceuticals Ltd | 16 | 2015-09-01 | 2018-06-06 |
Basal Cell Nevus Syndrome (3) · Carcinoma, Basal Cell (2) · Skin Neoplasms (1)
gusacitinib (3) · Fluorouracil (1)
Australia (2) · United States (1)
Gregory Siller (2) · Anna Bar (1) · Clement Leong (1) · Clement Leong, Ph.D (1) · Lynda Spelman (1) · Rodney Sinclair (1)